(2024)
In vitro antibacterial activity of microbial natural products against bacterial pathogens of veterinary and zoonotic relevance.
Antibiotics (Basel) 13(2),
135.
Dr. Florian Kloß
AlumniPublications
(2024)
Modulation of the Meisenheimer complex metabolism of nitro-benzothiazinones by targeted C-6 substitution.
Commun Chem 7(1),
153.
(2024)
Deazaflavin metabolite produced by endosymbiotic bacteria controls fungal host reproduction.
ISME J 18(1),
wrae074.
(2024)
Replacement of the essential nitro group by electrophilic warheads towards nitro-free antimycobacterial benzothiazinones.
Eur J Med Chem 279,
116849.
(2023)
Prenylated isoflavanones with antimicrobial potential from the root bark of Dalbergia melanoxylon.
Metabolites 13(6),
678.
(2023)
Pharmacokinetics and efficacy of the Benzothiazinone BTZ-043 against Tuberculous Mycobacteria inside granulomas in the Guinea pig model.
Antimicrob Agents Chemother 67(4),
e0143822.
(2023)
Whole cell hydride Meisenheimer complex biotransformation guided optimization of antimycobacterial benzothiazinones.
Eur J Med Chem 264,
116023.
(2023)
Design and synthesis of benzofuran- and naphthalene-fused thiazinones as antimycobacterial agents.
Arch Pharm (Weinheim) 356(11),
e2300356.
(2022)
INCATE: a partnership to boost the antibiotic pipeline.
Nat Rev Drug Discov 21(9),
621-622.
(Review)
(2022)
Natural products in antibiotic development: is the success story over?
Curr Opin Biotechnol 78,
102783.
(Review)